Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)
China · Delayed Price · Currency is CNY 24.20
-0.54 (-2.18%)
At close: May 12, 2026
SHA:688739 Revenue
Liaoning Chengda Biotechnology had revenue of 273.35M CNY in the quarter ending March 31, 2026, a decrease of -23.73%. This brings the company's revenue in the last twelve months to 1.31B, down -21.84% year-over-year. In the year 2025, Liaoning Chengda Biotechnology had annual revenue of 1.39B, down -17.06%.
Revenue (ttm)
1.31B
Revenue Growth
-21.84%
P/S Ratio
7.62
Revenue / Employee
722.32K
Employees
1,788
Market Cap
9.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.39B | -285.95M | -17.06% |
| Dec 31, 2024 | 1.68B | -73.86M | -4.22% |
| Dec 31, 2023 | 1.75B | -64.90M | -3.58% |
| Dec 31, 2022 | 1.81B | -273.04M | -13.08% |
| Dec 31, 2021 | 2.09B | 92.47M | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition